Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of heavy menstrual bleeding in premenopausal women on factor Xa inhibitors
NL-OMON55056Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dabigatran and tranexamic acid in menstrual disorders and hypermenorrhea (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in pictorial bleeding assessment chart score. Started Feb 2020; status: active, not recruiting.
02
Drugs
dabigatrantranexamic acid
03
Conditions
menstrual disordershypermenorrhea
Beyond the preview
Go deeper on NL-OMON55056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55056.